We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised $52M Series A from Andreessen Horowitz …

We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised $52M Series A from Andreessen Horowitz …

We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised $52M Series A from Andreessen Horowitz …

We’re a hybrid AI + biotech start-up, developing novel deep learning and molecular simulation techniques to predict molecular properties and using them to accelerate the development of new medicines. We raised $52M Series A from Andreessen Horowitz …

Trucking insurance for the 21st century! This is a relatively antiquated industry with a ton of manual and heuristically-driven processes. Underwriting (assessing risk) is literally done in a spreadsheet (at best). We bring insurance experience, Wal…

Truveris is a well-established, venture-backed provider of innovative SaaS in the hopes of improving the pharmacy benefits industry and saving patients money on prescription drugs.